335 related articles for article (PubMed ID: 21529203)
1. Cost-effectiveness of transforaminal lumbar interbody fusion for Grade I degenerative spondylolisthesis.
Adogwa O; Parker SL; Davis BJ; Aaronson O; Devin C; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Aug; 15(2):138-43. PubMed ID: 21529203
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years.
Parker SL; Adogwa O; Bydon A; Cheng J; McGirt MJ
World Neurosurg; 2012 Jul; 78(1-2):178-84. PubMed ID: 22120269
[TBL] [Abstract][Full Text] [Related]
3. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data.
Carreon LY; Glassman SD; Ghogawala Z; Mummaneni PV; McGirt MJ; Asher AL
J Neurosurg Spine; 2016 Jun; 24(6):916-21. PubMed ID: 26895529
[TBL] [Abstract][Full Text] [Related]
4. A protocol of a randomized controlled multicenter trial for surgical treatment of lumbar spondylolisthesis: the Lumbar Interbody Fusion Trial (LIFT).
de Kunder SL; Rijkers K; van Kuijk SM; Evers SM; de Bie RA; van Santbrink H
BMC Musculoskelet Disord; 2016 Oct; 17(1):417. PubMed ID: 27716168
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis: comparative effectiveness and cost-utility analysis.
Parker SL; Mendenhall SK; Shau DN; Zuckerman SL; Godil SS; Cheng JS; McGirt MJ
World Neurosurg; 2014; 82(1-2):230-8. PubMed ID: 23321379
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of multilevel hemilaminectomy for lumbar stenosis-associated radiculopathy.
Parker SL; Fulchiero EC; Davis BJ; Adogwa O; Aaronson OS; Cheng JS; Devin CJ; McGirt MJ
Spine J; 2011 Aug; 11(8):705-11. PubMed ID: 21641874
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review comparing two-year patient-reported outcomes, costs, and healthcare resource utilization for TLIF vs. PLF for single-level degenerative spondylolisthesis.
Kim E; Chotai S; Stonko D; Wick J; Sielatycki A; Devin CJ
Eur Spine J; 2018 Mar; 27(3):661-669. PubMed ID: 28585094
[TBL] [Abstract][Full Text] [Related]
8. Cost per quality-adjusted life year gained of laminectomy and extension of instrumented fusion for adjacent-segment disease: defining the value of surgical intervention.
Adogwa O; Parker SL; Shau DN; Mendenhall SK; Devin CJ; Cheng JS; McGirt MJ
J Neurosurg Spine; 2012 Feb; 16(2):141-6. PubMed ID: 22054637
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Radiographic Comparison of Oblique Lateral Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion in Patients with L4/5 grade-1 Degenerative Spondylolisthesis.
He D; He W; Tian W; Liu B; Liu Y; Sun Y; Xing Y; Lang Z; Wang Y; Ma T; Liu M
Orthop Surg; 2023 Jun; 15(6):1477-1487. PubMed ID: 37154089
[TBL] [Abstract][Full Text] [Related]
10. A Cost-Effectiveness Comparison Between Open Transforaminal and Minimally Invasive Lateral Lumbar Interbody Fusions Using the Incremental Cost-Effectiveness Ratio at 2-Year Follow-up.
Gandhoke GS; Shin HM; Chang YF; Tempel Z; Gerszten PC; Okonkwo DO; Kanter AS
Neurosurgery; 2016 Apr; 78(4):585-95. PubMed ID: 26726969
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of interbody fusions versus posterolateral fusions in 137 patients with lumbar spondylolisthesis.
Bydon M; Macki M; Abt NB; Witham TF; Wolinsky JP; Gokaslan ZL; Bydon A; Sciubba DM
Spine J; 2015 Mar; 15(3):492-8. PubMed ID: 25463402
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Minimally Invasive and Open Transforaminal Lumbar Interbody Fusion for Grade 1 Degenerative Lumbar Spondylolisthesis: An Analysis of the Prospective Quality Outcomes Database.
Chan AK; Bisson EF; Bydon M; Foley KT; Glassman SD; Shaffrey CI; Wang MY; Park P; Potts EA; Shaffrey ME; Coric D; Knightly JJ; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; Mummaneni PV
Neurosurgery; 2020 Sep; 87(3):555-562. PubMed ID: 32409828
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of circumferential fusion for lumbar spondylolisthesis: propensity-matched comparison of transforaminal lumbar interbody fusion with anterior-posterior fusion.
Jazini E; Gum JL; Glassman SD; Crawford CH; Djurasovic M; Owens RK; Dimar JR; McGraw KE; Carreon LY
Spine J; 2018 Nov; 18(11):1969-1973. PubMed ID: 29705337
[TBL] [Abstract][Full Text] [Related]
14. Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention.
Adogwa O; Parker SL; Shau DN; Mendenhall SK; Aaronson O; Cheng JS; Devin CJ; McGirt MJ
J Neurosurg Spine; 2012 Feb; 16(2):135-40. PubMed ID: 22054639
[TBL] [Abstract][Full Text] [Related]
15. Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.
Massie LW; Zakaria HM; Schultz LR; Basheer A; Buraimoh MA; Chang V
Neurosurg Focus; 2018 Jan; 44(1):E8. PubMed ID: 29290133
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive versus open transforaminal lumbar interbody fusion for grade I lumbar spondylolisthesis: 5-year follow-up from the prospective multicenter Quality Outcomes Database registry.
Chan AK; Bydon M; Bisson EF; Glassman SD; Foley KT; Shaffrey CI; Potts EA; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Michalopoulos GD; Guan J; Haid RW; Agarwal N; Park C; Chou D; Mummaneni PV
Neurosurg Focus; 2023 Jan; 54(1):E2. PubMed ID: 36587409
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion: 2-year assessment of narcotic use, return to work, disability, and quality of life.
Adogwa O; Parker SL; Bydon A; Cheng J; McGirt MJ
J Spinal Disord Tech; 2011 Dec; 24(8):479-84. PubMed ID: 21336176
[TBL] [Abstract][Full Text] [Related]
18. Determination of the minimum improvement in pain, disability, and health state associated with cost-effectiveness: introduction of the concept of minimum cost-effective difference.
Parker SL; McGirt MJ
Neurosurgery; 2012 Dec; 71(6):1149-55. PubMed ID: 22986596
[TBL] [Abstract][Full Text] [Related]
19. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
[TBL] [Abstract][Full Text] [Related]
20. A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis.
Chan AK; Bisson EF; Bydon M; Glassman SD; Foley KT; Potts EA; Shaffrey CI; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; Mummaneni PV
Neurosurg Focus; 2019 May; 46(5):E13. PubMed ID: 31042655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
